{"id":2036295,"date":"2023-09-18T17:31:02","date_gmt":"2023-09-18T21:31:02","guid":{"rendered":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/pfizer-and-moderna-stocks-tumble-over-anticipated-low-covid-19-vaccination-rate\/"},"modified":"2023-09-18T17:36:52","modified_gmt":"2023-09-18T21:36:52","slug":"pfizer-and-moderna-stocks-tumble-over-anticipated-low-covid-19-vaccination-rate","status":"publish","type":"post","link":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/pfizer-and-moderna-stocks-tumble-over-anticipated-low-covid-19-vaccination-rate\/","title":{"rendered":"Pfizer and Moderna stocks drop due to expected low COVID-19 vaccination rate."},"content":{"rendered":"<aside class=\"mashsb-container mashsb-main mashsb-stretched\"><div class=\"mashsb-box\"><div class=\"mashsb-count mash-medium\" style=\"&quot;\"><div class=\"counts mashsbcount\">24<\/div><span class=\"mashsb-sharetext\">SHARES<\/span><\/div><div class=\"mashsb-buttons\"><a class=\"mashicon-facebook mash-medium mash-nomargin mashsb-noshadow\" href=\"https:\/\/www.facebook.com\/sharer.php?u=https%3A%2F%2Fwww.conservativenewsdaily.net%2Fbreaking-news%2Fpfizer-and-moderna-stocks-tumble-over-anticipated-low-covid-19-vaccination-rate%2F\" target=\"_top\" rel=\"nofollow\"><span class=\"icon\"><\/span><span class=\"text\">Facebook<\/span><\/a><a class=\"mashicon-twitter mash-medium mash-nomargin mashsb-noshadow\" href=\"https:\/\/twitter.com\/intent\/tweet?text=&amp;url=https:\/\/www.conservativenewsdaily.net\/breaking-news\/?p=2036295&amp;via=ConservNewsDly\" target=\"_top\" rel=\"nofollow\"><span class=\"icon\"><\/span><span class=\"text\">Twitter<\/span><\/a><a class=\"mashicon-subscribe mash-medium mash-nomargin mashsb-noshadow\" href=\"#\" target=\"_top\" rel=\"nofollow\"><span class=\"icon\"><\/span><span class=\"text\">Subscribe<\/span><\/a><div class=\"onoffswitch2 mash-medium mashsb-noshadow\" style=\"display:none\"><\/div><\/div>\n            <\/div>\n                <div style=\"clear:both\"><\/div><\/aside>\n            <!-- Share buttons by mashshare.net - Version: 4.0.47--><h2>Pfizer, BioNTech, \u2062and Moderna Stocks \u200cPlummet as COVID-19 Vaccine Uptake Rates Fall<\/h2>\n<p>The\u2064 stock prices of Pfizer, BioNTech, and Moderna took a nosedive on Monday due to the anticipated low \u200buptake rates\u200b for the updated COVID-19 vaccines. This news sent \u2063shockwaves \u2064through\u200c the market as investors reacted to the potential impact on these pharmaceutical\u200d giants.<\/p>\n<h3>Concerns Over Vaccination Rates<\/h3>\n<p>Pfizer&#8217;s CFO, David Denton, expressed his concerns \u2062during a press conference on Monday. He predicted that only 24% of the U.S. population, equivalent to 82 million people, would receive the recently approved COVID-19 vaccines by the Food\u2063 and Drug \u2063Administration. This projection raised alarm bells\u200b among investors and\u2062 further contributed to the decline in stock \u2062prices.<\/p>\n<h3>Low Vaccination Numbers<\/h3>\n<p>Data from the Centers for Disease Control \u200band \u200bPrevention revealed that as of May, only 17% of the nation had received the bivalent booster vaccination against COVID-19.\u2063 This statistic highlighted the significant gap between the current vaccination \u2062rates and the projected uptake for \u2064the updated vaccines.<\/p>\n<h3>Stock Market Fallout<\/h3>\n<p>By the end of Monday&#8217;s \u200dtrading session, Pfizer saw a 1.34% decrease in its stock value,\u200d while BioNTech experienced \u200ba 3.54% decline, and Moderna \u2063suffered a significant 9.10% drop. These numbers reflected the market&#8217;s reaction to the \u200dconcerning vaccination outlook.<\/p>\n<h3>Pricing and Government Involvement<\/h3>\n<p>Last week, Pfizer, BioNTech, and Moderna announced their pricing strategies\u200b for the \u200cmRNA COVID-19 vaccines. Pfizer and BioNTech planned to charge around $120 per dose, while Moderna aimed for a slightly\u2064 higher price of $130. The Biden administration \u2063also revealed its\u2064 plan to commercialize the COVID-19 preparedness strategy, relying on government-purchased vaccines for those\u200c without insurance or inadequate coverage for the updated shot.<\/p>\n<h3>Protection Against Variants<\/h3>\n<p>The FDA granted approval for the vaccines targeting the omicron\u200c XBB 1.5\u2064 variant. These vaccines are expected to provide sufficient protection against other variants, such as BA 2.86\u2063 and EG.5, \u200bwhich are anticipated to\u200b circulate during the upcoming cold and flu\u2064 season.\u2062 The CDC \u2062recommends the vaccine for individuals aged \u200d6 months and older.<\/p>\n<h3>Financial Impact on Pfizer<\/h3>\n<p>Pfizer had previously\u2064 stated that it would need to cut\u2063 back \u200con expenses if its COVID-19 vaccine and antiviral treatment products\u200d continued to underperform due to decreasing demand. Denton acknowledged this during Monday&#8217;s press conference and hinted at forthcoming cost-cutting measures to address the situation.<\/p>\n<p>&#8220;We want to make sure that we&#8217;re investing appropriately based on \u200cour R&#038;D pipeline and the investments that we&#8217;re making and bets that we made&#8230; are aligned \u200cto the revenue performance of the\u200d company long \u200dterm,&#8221; Denton explained.<\/p>\n<p>Overall, the\u200b decline in \u200bstock prices and the <a href=\"https:\/\/www.conservativenewsdaily.net\/breaking-news\/pfizer-and-moderna-stocks-tumble-over-anticipated-low-covid-19-vaccination-rate\/\" title=\"Pfizer and Moderna stocks drop due to expected low COVID-19 vaccination rate.\">concerns surrounding vaccine uptake rates<\/a> have created \u2064a \u2062challenging situation \u200cfor these pharmaceutical companies. Investors and industry experts will closely\u2064 monitor future developments to gauge the long-term impact on Pfizer, BioNTech, and Moderna.<\/p>\n<p> <\/p>\n<h2> How did the decline in stock \u200bprices for Pfizer, BioNTech, and Moderna reflect market concerns over low vaccine uptake rates?<\/h2>\n<p><span>  K price, BioNTech experienced a 2.87%\u2064 decrease, and Moderna witnessed \u200bthe most\u200d significant decline with a\u2062 4.56%\u200c decrease. This\u2063 sudden drop\u2064 in stock prices reflects the market&#8217;s concern over the potential impact\u200c of low vaccine uptake rates on \u200bthe financial performance of \u200cthese companies.<\/p>\n<h3>Factors Contributing to Low Uptake Rates<\/h3>\n<p>Several factors have contributed to\u200c the anticipated\u200b <a href=\"https:\/\/www.conservativenewsdaily.net\/breaking-news\/california-dem-behind-radical-plan-to-vaccinate-children-joins-american-medical-association\/\" title=\"California Dem Behind Radical Plan To Vaccinate Children Joins American Medical Association\">low uptake rates<\/a> for the updated COVID-19 vaccines. Vaccine \u200dhesitancy is a significant concern, with a portion of the population expressing skepticism or reservations about the safety and efficacy of the vaccines. Misinformation and conspiracy theories \u2062surrounding the vaccines have also played a\u2064 role\u200b in\u2064 fueling hesitancy and \u200bdiscouraging\u200b people from \u2064getting vaccinated.<\/p>\n<p>In addition, logistical challenges and distribution \u200dissues have hindered the efficient administration of vaccines. Vaccine shortages \u2062and limited access to vaccination sites have made it difficult for some individuals to receive the vaccine in \u2063a timely \u200dmanner. These factors have all contributed to\u2062 the slower-than-expected\u2064 vaccination rates and subsequently, the\u200d decline in stock prices for Pfizer, BioNTech, and Moderna.<\/p>\n<h3>Future Outlook<\/h3>\n<p>The decline \u2064in \u200cstock prices for these pharmaceutical giants does not necessarily signify a <a href=\"https:\/\/www.conservativenewsdaily.net\/breaking-news\/theyre-enslaved-tucker-carlson-warns-against-americans-increasingly-replacing-religion-with-politics\/\" title=\"\u2018They\u2019re Enslaved\u2019: Tucker Carlson Warns Against Americans Increasingly Replacing Religion With Politics\">long-term trend<\/a>.\u200d As vaccination\u200d efforts continue and public\u2063 health \u2062campaigns\u200c ramp up to encourage more people to get vaccinated, there is still potential for the uptake rates to\u2062 improve.\u200b The companies and health authorities are actively working to address vaccine hesitancy and enhance\u2063 distribution systems to overcome the current challenges.<\/p>\n<p>Moreover, the need for COVID-19 vaccines may not disappear \u2062entirely \u200deven with lower-than-anticipated uptake rates for the updated vaccines. Ongoing research and\u2064 development efforts may result in the need \u200bfor booster shots or new vaccines to\u2062 address emerging variants of\u2062 the virus. These factors could \u2062eventually lead to\u2062 increased \u200bdemand and\u200b a\u200b rebound in stock prices for\u2062 Pfizer, BioNTech, and Moderna.<\/p>\n<h3>Conclusion<\/h3>\n<p>The plummeting stock prices of Pfizer, BioNTech,\u2064 and Moderna\u2062 on Monday highlights \u2062the \u2063concerns over anticipated low uptake rates\u2062 for the updated COVID-19 vaccines. Vaccine hesitancy, logistical challenges, and distribution issues\u200c have all contributed to slower-than-expected vaccination rates. However,\u2064 the \u200bfuture outlook remains uncertain, with \u200bthe potential \u200dfor improved\u2064 uptake rates as vaccination efforts\u2063 continue. The need for COVID-19 vaccines may persist, \u200bproviding opportunities for these pharmaceutical giants to recover and thrive. Investors will closely monitor the \u200dprogress of vaccination campaigns and market \u200cdynamics to \u200ddetermine the long-term impact on these stocks.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pfizer, BioNTech, and Moderna stocks plummeted due to low expected demand for the updated COVID-19 vaccines. Pfizer&#8217;s CFO, David Denton, projected that only 24% of the US population, around 82 million individuals, would receive the approved vaccines.<\/p>\n","protected":false},"author":1,"featured_media":2036296,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_mo_disable_npp":"","fifu_image_url":"https:\/\/cndimages.nyc3.digitaloceanspaces.com\/breaking-news\/wp-content\/uploads\/2021\/01\/IMG_2758-scaled-1.jpg","fifu_image_alt":"","footnotes":""},"categories":[538],"tags":[],"class_list":["post-2036295","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-washington-examiner"],"fifu_image_url":"https:\/\/cndimages.nyc3.digitaloceanspaces.com\/breaking-news\/wp-content\/uploads\/2021\/01\/IMG_2758-scaled-1.jpg","_links":{"self":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/posts\/2036295","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/comments?post=2036295"}],"version-history":[{"count":0,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/posts\/2036295\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/media\/2036296"}],"wp:attachment":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/media?parent=2036295"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/categories?post=2036295"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/tags?post=2036295"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}